Precision Neuroscience Attracts Deal-by-Deal SPV: Angel Capital Follows BCI Into the Access Layer

Precision Neuroscience Attracts Deal-by-Deal SPV: Angel Capital Follows BCI Into the Access Layer

HII Precision Neuroscience-01, a Series of HII Precision Neuroscience LLC, filed USD 1.67 million on August 20, with Christopher Charles DeLap as key person. The vehicle represents an angel-level SPV providing accredited investors with structured access to Precision Neuroscience, a New York-based brain-computer interface startup that raised USD 102 million in a Series C round in December 2024. The August 20 filing adds to a pattern of secondary access vehicles being created for frontier hardware companies as their valuations grow beyond the reach of typical angel round minimums.

What Precision Neuroscience Builds

Founded in 2021 by Michael Mager and Benjamin Rapoport, Precision Neuroscience develops the Layer 7 Cortical Interface, a minimally invasive, ultrathin cortical implant designed to capture brain signals from the surface of the cortex without penetrating neural tissue. The design philosophy distinguishes Precision from Neuralink, whose N1 implant requires penetrating electrode insertion. Precision's approach is designed for broader clinical application: the company believes that a minimally invasive implant that can be placed by a standard neurosurgeon in a procedure similar to conventional brain surgery is more likely to achieve the scale of clinical deployment needed to build a commercially viable BCI platform.

Precision's 2026 milestones include a partnership with Medtronic to integrate the Layer 7 interface with Medtronic's neurosurgical navigation platform, and appointments of prominent neuroscientists to its scientific advisory board. The Medtronic partnership is significant: Medtronic is the world's largest medical device company, and its willingness to integrate Precision's technology into its surgical workflow signals clinical validation at the highest institutional level.

Deal-by-Deal Access to Frontier Hardware

The HII filing is part of a cluster of access vehicles filed on August 20 targeting frontier hardware companies. In the same session, HII Lightmatter-03, a Series of HII Lightmatter LLC, filed USD 3.38 million for accredited investor access to Lightmatter, the photonic AI compute startup that raised USD 400 million in October 2024 at a USD 4.4 billion valuation. Both filings reflect the growing secondary market for deep tech hardware startups whose equity is held tightly by institutional investors and corporate strategic partners.

For context on how the broader frontier hardware investment landscape has evolved in 2026, we covered photonic AI compute in our earlier report on OLIX's $312M photonic AI chip round, a company building the optical processing infrastructure that Lightmatter and similar companies depend on for next-generation AI compute architectures. The secondary market vehicles for both Lightmatter and Precision Neuroscience confirm that photonic compute and BCI are no longer seen as purely speculative categories.

What This Means for Founders

The creation of SPV access vehicles around Precision Neuroscience and Lightmatter reflects a secondary market that is now reaching into deep tech hardware categories that were previously not liquid enough to support this kind of structured access. For founders building in BCI, photonics, semiconductor design, or other frontier hardware categories, this is a meaningful signal: the secondary market is confirming that frontier hardware is now a legitimate investable category for a broader base of capital beyond the institutional VC funds that led the primary rounds.

Understanding your burn rate relative to your hardware development timeline is especially important in deep tech: hardware companies typically have longer runways between milestones than software companies, and investors in this category expect to see this modelled explicitly in fundraising conversations. Use the investor match tool to find funds that have explicitly backed deep tech hardware at your stage. Deeptech and biotech founders can also explore active investors in deeptech on AngelLinx for the full landscape of funds building positions in frontier hardware and life science categories.

Find investors backing frontier hardware and deep tech startups @ angellinx.ai/register.


AngelLinx Intelligence | angellinx.ai